DÄ internationalArchive40/2019Evidence-based follow-up for adults with cancer

Review article

Evidence-based follow-up for adults with cancer

Dtsch Arztebl Int 2019; 116: 663-9. DOI: 10.3238/arztebl.2019.0663

Dührsen, U; Deppermann, K; Pox, C; Holstege, A

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Klinik für Hämatologie, Universitätsklinikum Essen: Prof. Dr. med. Ulrich Dührsen
Klinik für Pneumologie, Sana Kliniken Düsseldorf: Dr. med. Karl-Matthias Deppermann
Medizinische Klinik, Krankenhaus St. Josef-Stift Bremen: PD Dr. med. Christian Pox
Medizinische Klinik 1, Klinikum Landshut: Prof. Dr. med. Axel Holstege (Emeritus)
1.Kenzik KM: Health care use during cancer survivorship: review of 5 years of evidence. Cancer 2019; 125: 673–80 CrossRef MEDLINE
2.Burns PB, Rohrich RJ, Chung KC: The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg 2011; 128: 305–10 CrossRef MEDLINE PubMed Central
3.Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie: Onkopedia-Leitlinien. www.onkopedia.com/de/onkopedia/guidelines (last accessed on 18 February 2019).
4.AWMF online. Aktuelle Leitlinien. www.awmf.org/leitlinien/aktuelle-leitlinien.html (last accessed on 6 April 2019).
5.Zentrum für Krebsregisterdaten. Krebs in Deutschland 2013/2014. www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/krebs_in_deutschland_node.html (last accessed on 31 March 2019).
6.Schmiegel W, Buchberger B, Follmann M, et al.: S3-Leitlinie – Kolorektales Karzinom. Z Gastroenterol 2017; 55: 1344–498 CrossRef MEDLINE
7.Leitlinienprogramm Onkologie: S3-Leitlinie Kolorektales Karzinom. Langversion 2.1 – Januar 2019. AWMF-Registernummer: 021/007OL. www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Kolorektales_Karzinom/Version_2/LL_KRK_Langversion_2.1.pdf (last accessed on 29 March 2019).
8.Kievit J: Colorectal cancer follow-up: a reassessment of empirical evidence on effectiveness. Eur J Surg Oncol 2000; 26: 322–8 CrossRef MEDLINE CrossRef MEDLINE
9.Kievit J: Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 2002; 38: 986–99 CrossRef CrossRef
10.Jeffery M, Hickey BE, Hider PN, See AM: Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2016; 11: CD002200 CrossRef PubMed Central
11.Snyder RA, Hu CY, Cuddy A, et al.: Association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer. JAMA 2018; 319: 2104–15 CrossRef MEDLINE PubMed Central
12.Leitlinienprogramm Onkologie: S3-Leitlinie Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. Langversion 1.0 – Februar 2018. AWMF-Registernummer: 020/007OL. www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/ Leitlinien/Lungenkarzinom/LL_Lungenkarzinom_Langversion_1.0.pdf (last accessed on 31 March 2019).
13.Colice GL, Rubins J, Unter M: Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest 2003; 123: 272S–83S CrossRef MEDLINE
14.Moore S, Corner J, Haviland J, et al.: Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomized trial. BMJ 2002; 325: 1145 CrossRef MEDLINE PubMed Central
15.Nakamura R, Kurishima K, Kobayashi N, et al.: Postoperative follow-up for patients with non-small cell lung cancer. Onkologie 2010; 33: 14–8 CrossRef MEDLINE
16.Virgo KS, McKirgan LW, Caputo MC, et al.: Post-treatment management options for patients with lung cancer. Ann Surg 1995; 222: 700–10 CrossRef MEDLINE PubMed Central
17.Westeel V, Choma D, Clément F, et al.: Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg 2000; 70: 1185–90 CrossRef
18.Younes RN, Gross JL, Deheinzelin D: Follow-up in lung cancer: how often and for what purpose? Chest 1999; 115: 1494–9 CrossRef MEDLINE
19.Schmidt-Hansen M, Baldwin DR, Hasler E: What is the most effective follow-up model for lung cancer patients? A systematic review. J Thorac Oncol 2012; 7: 821–4 CrossRef MEDLINE
20.National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, et al.: Reduced lung-cancer mortality with low-dose computed tomography screening. N Engl J Med 2011; 365: 395–409 CrossRef MEDLINE PubMed Central
21.Stang A, Schuler M, Kowall B, Darwiche K, Kühl H, Jöckel KH: Lung cancer screening using low dose CT scanning in Germany—extrapolation of results from the National Lung Screening Trial. Dtsch Arztebl Int 2015; 112: 637–44 CrossRef MEDLINE PubMed Central
22.Lister TA, Crowther D, Sutcliffe SB, et al.: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin‘s disease: Cotswolds meeting. J Clin Oncol 1989; 7: 1630–6 CrossRef MEDLINE
23.Cheson BD, Fisher RI, Barrington SF, et al.: Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014; 32: 3059–68 CrossRef MEDLINE PubMed Central
24.Leitlinienprogramm Onkologie: Konsultationsfassung S3-Leitlinie Diagnostik, Therapie und Nachsorge des Hodgkin Lymphoms bei erwachsenen Patienten. Langversion 0.2.0 – Dezember 2017, AWMF-Registernummer 018/029. www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Hodgkin/Version_2/LL_Hodgkin_Lymphom_Langversion_Konsultationsfassung_0_2_0.pdf (last accessed on 18 February 2019).
25.Sussman J, Varela NP, Cheung M, et al.: Follow-up care for survivors of lymphoma who have received curative-intent treatment. Curr Oncol 2016; 23: e499–e513 CrossRef MEDLINE PubMed Central
26.Hiniker SM, Hoppe RT: Post-treatment surveillance imaging in lymphoma. Semin Oncol 2017; 44: 310–22 CrossRef MEDLINE
27.Scholz-Kreisel P, Kaatsch P, Spix C, et al.: Second malignancies following childhood cancer treatment in Germany from 1980 to 2014—a registry-based analysis. Dtsch Arztebl Int 2018; 115: 385–92 VOLLTEXT
28.Damlaj M, El Fakih R, Hashmi SK: Evolution of survivorship in lymphoma, myeloma and leukemia: metamorphosis of the field into long term follow-up care. Blood Rev 2019; 33: 63–73 CrossRef MEDLINE
29.Ng AK, LaCasce A, Travis LB: Long-term complications of lymphoma and its treatment. J Clin Oncol 2011; 29: 1885–92 CrossRef MEDLINE
30.Pryzant RM, Meistrich ML, Wilson G, et al.: Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin‘s lymphomas. J Clin Oncol 1993; 11: 239–47 MEDLINE
31.Elis A, Tevet A, Yerushalmi R, et al.: Fertility status among women treated for aggressive non-Hodgkin‘s lymphoma. Leuk Lymphoma 2006; 47: 623–7 CrossRef MEDLINE
32.Picardi M, Pugliese N, Cirillo M, et al.: Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission—a randomized trial of routine surveillance imaging procedures. Radiology 2014; 272: 262–74 CrossRef MEDLINE
33.Chien SH, Liu CJ, Hu YW, et al.: Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies:a nationwide population-based study. Int J Cancer 2015; 137: 658–65 CrossRef MEDLINE
34.Brandenbarg D, Berendsen AJ, de Bock GH: Patients‘ expectations and preferences regarding cancer follow-up care. Maturitas 2017; 105: 58–63 CrossRef MEDLINE
35.Thompson CA, Charlson ME, Schenkein E, et al.: Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann Oncol 2010; 21: 2262–6 CrossRef MEDLINE PubMed Central